Mass prostate cancer screening doesn't reduce deaths: study
There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington ...
Cancer
Jan 06, 2012 |
4 / 5 (2) |
6
|
Erectile dysfunction drug also helps men ejaculate and orgasm
New data suggests the erectile dysfunction (ED) drug Cialis may also be beneficial in helping men who have problems with ejaculation and orgasm, report researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
5 / 5 (2) |
0
|
How prostate cancer therapies compare by cost and effectiveness
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team ...
Cancer
Jan 04, 2013 |
not rated yet |
1
|
Researchers identify link between kidney removal and erectile dysfunction
Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction. Results from the multi-center ...
Diseases, Conditions, Syndromes
Jul 30, 2012 |
4.5 / 5 (2) |
0
|
A new screening method for prostate cancer
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically ...
Cancer
Feb 02, 2012 |
4 / 5 (1) |
0
|
Genetic test helps predict risk of prostate cancer recurrence
(Medical Xpress)—Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
Cancer
May 10, 2013 |
not rated yet |
0
High doses of saw palmetto appear safe over 18 months
(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.
Diseases, Conditions, Syndromes
Apr 29, 2013 |
5 / 5 (1) |
0
Collagenase clostridium histolyticum OK in Peyronie's
(HealthDay)—For patients with Peyronie's disease, treatment with collagenase clostridium histolyticum (CCH) intralesional injections is efficacious and tolerable, according to research published online ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
not rated yet |
0
Rate of nephrectomy at lymph node dissection is declining
(HealthDay)—Over the last 30 years, the incidence of nephrectomy at post-chemotherapy (PC) retroperitoneal lymph node dissection (RPLND) has steadily declined, according to research published in the March ...
Diseases, Conditions, Syndromes
Apr 03, 2013 |
not rated yet |
0
Kidney stone surgery: More women, more complications with minimally invasive procedure
While the number of people – especially women – who have a minimally invasive procedure to remove kidney stones has risen in recent years, so has the rate of complications related to the surgery, according to a published ...
Surgery
Mar 27, 2013 |
not rated yet |
0
Low-risk bladder cancer rarely progresses to muscle invasion
(HealthDay)—Low-risk bladder cancer rarely progresses to muscle invasion but is associated with an increased risk of disease-specific mortality compared with matched populations, according to research published ...
Cancer
Mar 06, 2013 |
not rated yet |
0
Biopsy-based algorithm found accurate for small renal masses
(HealthDay)—Compared with final pathology, biopsy of small renal masses (SRMs) can be accurately used in a treatment algorithm to direct management, according to research published in the February issue ...
Diseases, Conditions, Syndromes
Feb 09, 2013 |
not rated yet |
0
High doses of saw palmetto don't impact serum PSA
(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Older individuals have atypical stone presentation
(HealthDay)—Older individuals are more likely to have atypical presentation with urolithiasis, according to a study published in the January issue of The Journal of Urology.
Diseases, Conditions, Syndromes
Jan 16, 2013 |
not rated yet |
0
Change in PSA levels over time can help predict aggressive prostate cancer
Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when compared to a single measurement ...
Cancer
Jan 15, 2013 |
not rated yet |
0
